Eric Moyal ’17, MA’18, MS’21 is working to disrupt the drug industry and bring an end to sky-high prices for the life-saving medication Eric Moyal ’17, MA’18, MS’21 is on a mission to make insulin ...

David Goeddel is a pioneer of the biotechnology industry who, employed at the time by Genentech, successfully used genetic engineering to coax bacteria into creating synthetic human insulin, human ...

Fussenegger and his colleagues engineered human embryonic kidney cells that produce a synthetic version of human glucagon-like peptide 1 (GLP-1), a molecule that prompts the release of insulin, in the ...